📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adjunctive ivermectin mass drug administration for malaria control on the Bijagos Archipelago of Guinea-Bissau (MATAMAL): a quadruple-blinded, cluster-randomised, placebo-controlled trial. (2024)

First Author: Hutchins H

Attributed to: Adjunctive Ivermectin Mass Drug Administration for Malaria Elimination: A cluster randomized trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00580-2

PubMed Identifier: 39551062

Publication URI: http://europepmc.org/abstract/MED/39551062

Type: Journal Article/Review

Parent Publication: The Lancet. Infectious diseases

ISSN: 1473-3099